Definitive Contract HHSF223201610125C

Award Date 9/16/16
Potential Completion Date 12/31/19
Potential Value $597K
Awardee
QPS LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newark, DE, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
67
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a small business contractor, in the amount of $167,767.00. The contract is for a "Fragrance Study Titled, 'Evaluation of the Allergenicity and Sensitization Potential of Fragrance Substances Based on Survey of Scientific Literature.'" As a small business set-aside contract, ILS will conduct this research study on the allergenicity and...
The National Heart Lung and Blood Institute (NHLBI) of the U.S. Department of Health and Human Services awarded a $18,600.00 firm-fixed-price purchase order contract to QPS LLC, a minority-owned limited liability company, to provide laboratory testing and LC-MS/MS analysis of the compound R940406 in monkey plasma samples supporting a non-GLP study. The contract has an ultimate completion date of January 30, 2025 and was awarded on August 8, 2024. This contract is not designated as a set-aside.
This is a delivery order contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Ihrc, Incorporated, a self-certified small disadvantaged, woman-owned business. The contract is for a Subject Matter Expert to support the development and evaluation of microbiological methods for cosmetics. It is a firm fixed price contract with a potential value of $798,872.66 and a completion date of August 16, 2023. The contract was issued under the FDA's...
This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $6,561,386.54 contract is for a range of clinical and laboratory applied regulatory science services that support the FDA's regulatory science programs and decision-making across product lifecycles. Services include conducting clinical...
This is a task order issued by the Food and Drug Administration (FDA) to Computer Evidence Specialists, LLC (CES), a minority-owned, service-disabled veteran-owned small business. The task order is for 30,950 units of unspecified supplies (UBS), 1,000 units of unspecified supplies (A & L's), 2,267 hours of program management, non-inspection travel, and other direct costs to complete inspections in Virginia. The FDA is also modifying the contract to change the IPP reportable flag field from...
The Department of Health and Human Services Food and Drug Administration awarded a $393,387 definitive contract to Pacific Force Consulting Group LLC. The contract calls for the contractor to conduct quality management maturity assessments at up to nine domestic FDA facilities using their established assessment tool. Additionally, the contractor must train FDA staff to independently conduct similar evaluations. This opportunity was set aside for total small businesses and addresses the...
This federal contract award is for a RESEARCH SCIENTIST II position with the Department of Health and Human Services (HHS) Food and Drug Administration (FDA), with a potential value of $128,025.60. The contract was awarded to the prime contractor, McNeal Professional Services, Inc. (MPS), a self-certified small disadvantaged business, woman-owned small business, and Black American-owned Subchapter S corporation. The contract is a Delivery Order under the Temporary Administrative and Professional...
This federal contract award to QPS LLC, a minority-owned limited liability company, is for the provision of rodent pharmacokinetic (PK) testing services to support the National Institute of Neurological Disorders and Stroke's (NINDS) Helping to End Addiction Long-term (HEAL) initiative. The $98,000.00 firm-fixed-price purchase order contract has a period of performance through September 22, 2025. The contract was competitively awarded and does not have a set-aside designation. The services to be...
<p>This is a firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Sequoia Research Products LTD, a foreign-owned for-profit organization, for a study on drug repositioning. The contract has a ceiling value of $124,852.00 and an ultimate completion date of October 17, 2015. The contract is not set aside for any specific type of business. No further details about a larger contract vehicle are provided.</p>

This is a $597,340.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA) to QPS LLC, a minority-owned limited liability company, for a scientific study related to the assessment of in vitro percutaneous absorption, in vitro rate of release, and physicochemical properties. The contract does not have a set-aside designation, indicating it was an open market procurement. QPS LLC is an experienced federal contractor, having been awarded multiple contracts and task orders by various health research agencies, including the National Institute of Neurological Disorders and Stroke, the National Heart Lung and Blood Institute, and the National Center for Advancing Translational Sciences, for specialized laboratory testing and analysis services. This contract with the FDA is for work to be completed by December 31, 2019.

Generated 4/1/25, 4:44 PM